Cardiotoxicity in Chinese cancer patients treated with 5-fluorouracil or capecitabine: A multicenter prospective observational study

被引：0
|
作者：
Chen, G. [1 ]
Peng, J. J. [2 ]
Dong, C. [3 ]
Qiu, M. [4 ]
Wang, C. [5 ]
Li, H. W. [6 ]
Yu, H. [7 ]
Zhang, M. [8 ]
Zhao, Q. [9 ]
Zhu, B. [10 ]
Zhang, J. [11 ]
Li, L. W. [12 ]
Wang, H. F. [13 ]
Wu, Q. [14 ]
Yuan, Y. [15 ]
Zhou, H. W. [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Colorectal, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Gastrointestinal Pancreat Surg, Guangzhou, Guangdong, Peoples R China
[3] Kunming Med Coll, Affiliated Hosp 3, Yunnan Tumour Hosp, Yunnan Canc Hosp, Kunming, Peoples R China
[4] Sichuan Univ, West China Hosp, Oncol, Chengdu, Peoples R China
[5] Jilin Univ, Bethune Hosp 1, Hematol Oncol, Changchun, Peoples R China
[6] Fujian Prov Hosp, Surg Oncol, Fuzhou, Peoples R China
[7] Nanjing Med Univ, Biol Stat, Nanjing, Jiangsu, Peoples R China
[8] Shanghai Chest Hosp, Cardiol, Shanghai, Peoples R China
[9] Hebei Canc Hosp, Surg Oncol, Shijiazhuang, Peoples R China
[10] 3rd Mil Med Univ, Xinqiao Hosp, Oncol, Chongqing, Peoples R China
[11] Shanghai Jiao Tong Univ, Coll Med, Shanghai Ruijin Hosp, Oncol, Shanghai, Peoples R China
[12] Kunming Med Univ, Affiliated Hosp 1, Oncol, Kunming, Peoples R China
[13] Sun Yat Sen Univ, Ctr Canc, Internal Med, Guangzhou, Guangdong, Peoples R China
[14] Bengbu Med Coll, Affiliated Hosp 1, Med Oncol, Bengbu, Peoples R China
[15] Zhejiang Univ, Univ Sch Med, Affiliated Hosp 2, Med Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
572P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cardiotoxicity in Chinese cancer patients treated with 5-fluorouracil or capecitabine: A multicenter prospective observational study.
    Chen, Gong
    Peng, Jianjun
    Dong, Chao
    Qiu, Meng
    Wang, Chang
    Li, Hua Wei
    Yu, Hao
    Zhang, Min
    Zhao, Qun
    Zhu, Bo
    Zhang, Jun
    Li, Wenliang
    Wang, Fenghua
    Wu, Qiong
    Yuan, Ying
    Zhou, Wen-hao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
    Peng, Jianjun
    Dong, Chao
    Wang, Chang
    Li, Weihua
    Yu, Hao
    Zhang, Min
    Zhao, Qun
    Zhu, Bo
    Zhang, Jun
    Li, Wenliang
    Wang, Fenghua
    Wu, Qiong
    Zhou, Wenhao
    Yuan, Ying
    Qiu, Meng
    Chen, Gong
    [J]. CANCER COMMUNICATIONS, 2018, 38
  • [3] Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
    Polk, Anne
    Vaage-Nilsen, Merete
    Vistisen, Kirsten
    Nielsen, Dorte L.
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (08) : 974 - 984
  • [4] Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer
    Dyhl-Polk, Anne
    Vaage-Nilsen, Merete
    Schou, Morten
    Vistisen, Kirsten Kjeldgaard
    Lund, Cecilia Margareta
    Kumler, Thomas
    Appel, Jon Michael
    Nielsen, Dorte
    [J]. ACTA ONCOLOGICA, 2020, 59 (04) : 475 - 483
  • [5] Bolus 5-Fluorouracil as an Alternative in Patients with Cardiotoxicity Associated with Infusion 5-Fluorouracil and Capecitabine: A Case Series
    Saif, Muhammad Wasif
    Garcon, Marie Carmel
    Rodriguez, Gladys
    Rodriguez, Teresa
    [J]. IN VIVO, 2013, 27 (04): : 531 - 534
  • [6] Bolus 5-Fluorouracil as an Alternative Modality to Infusion 5-Fluorouracil in a Patient with Rectal Cancer and Capecitabine-induced Cardiotoxicity
    Shaib, Walid
    Lee, Veronica
    Saif, M. Wasif
    [J]. IN VIVO, 2009, 23 (05): : 821 - 826
  • [7] Cardiotoxicity of 5-fluorouracil in patients with gastrointestinal cancer.
    Lopez, Lourdes
    Montenegro, Paola Catherine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [8] Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine
    Jensen, SA
    Sorensen, JB
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 487 - 493
  • [9] Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine
    Søren Astrup Jensen
    Jens Benn Sørensen
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 58 : 487 - 493
  • [10] 5-Fluorouracil Degradation Rate in Patients with Recurrent Gastrointestinal Cancer Treated with Metronomic Capecitabine
    Roberto, M.
    Romiti, A.
    Lionetto, L.
    D'Antonio, C.
    Onesti, C.
    Botticelli, A.
    Milano, A.
    Falcone, R.
    Occhipinti, M.
    Mazzuca, F.
    Simmaco, M.
    Marchetti, P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 12 - 12
12345